Sun Pharma arm gets USFDA nod for epilepsy drug

Sun Pharmaceutical Industries on Friday said one of its subsidiaries has received approval from the US health regulator to market Elepsia XR, an antiepileptic drug.

The United States Food and Drug Administration (USFDA) has granted approval for the New Drug Application to a wholly-owned subsidiary of Sun Pharma for Elepsia XR in the strengths of 1,000 mg and 1,500 mg, the company said in a regulatory filing.

The product was filed from Sun Pharma’s Halol (Gujarat) facility, it added.

The subsidiary concerned had in-licensed Elepsia XR from Sun Pharma Advanced Research Company (SPARC) in July 2016.

Sun Pharma shares settled at Rs 424.75 a piece, down 1.05 per cent on BSE.

  • Related Posts

    Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine

    In a significant step towards leveraging emerging technologies to strengthen the Ayush ecosystem, the Ministry of Ayush and IndiaAI, ministry of electronics and information technology (MeitY), signed a Memorandum of…

    BFUHS Pharmacy Exam Cheating Racket Busted; Punjab Police Arrest 35, Say No Paper Leak

    Punjab Police recently dismantled an interstate cheating operation linked to the BFUHS pharmacy exam. Education Minister Harjot Bains described it as a sophisticated, technology-driven scheme rather than a paper leak.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine

    Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine

    BFUHS Pharmacy Exam Cheating Racket Busted; Punjab Police Arrest 35, Say No Paper Leak

    BFUHS Pharmacy Exam Cheating Racket Busted; Punjab Police Arrest 35, Say No Paper Leak

    Rajasthan Raises Govt Blood Centres’ Share in Voluntary Donation Camps to 50%

    Rajasthan Raises Govt Blood Centres’ Share in Voluntary Donation Camps to 50%

    FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

    FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

    Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

    Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

    FSSAI Issues Prohibition Orders against FOLINEURO Syrup and Neuherbs TRUE VITAMIN over Misleading Claims

    FSSAI Issues Prohibition Orders against FOLINEURO Syrup and Neuherbs TRUE VITAMIN over Misleading Claims